LEPTOMENINGEAL DISEASE
Clinical trials for LEPTOMENINGEAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL DISEASE trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells engineered to attack brain tumors in kids: new trial launches
Disease control Not yet recruitingThis early-phase study tests a personalized cell therapy called B7-H3 CAR T cells in 70 children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a prote…
Matched conditions: LEPTOMENINGEAL DISEASE
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 17, 2026 07:05 UTC
-
New MRI dye aims to catch rare brain cancer earlier
Diagnosis Not yet recruitingThis study tests whether a new contrast agent called gadopiclenol can improve MRI scans to detect leptomeningeal disease (LMD), a rare spread of cancer to the lining of the brain and spinal cord. About 40 adults with solid tumors who have unclear MRI results will receive the dye …
Matched conditions: LEPTOMENINGEAL DISEASE
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 13, 2026 15:59 UTC